MedPath

海南红祥旗荣医药科技有限公司

Ownership
-
Established
2021-09-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Vardenafil Hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20243123
Approval Date
Jan 30, 2024
NMPA

Vardenafil Hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20243124
Approval Date
Jan 30, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20223066
Approval Date
Jan 30, 2022
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20213748
Approval Date
Sep 24, 2021
NMPA

Pasiniazid Tablets

Product Name
帕司烟肼片
Approval Number
国药准字H21023038
Approval Date
Sep 2, 2020
NMPA

Protionamide Enteric-coated Tablets

Product Name
丙硫异烟胺肠溶片
Approval Number
国药准字H10983134
Approval Date
Jun 24, 2020
NMPA

Rifampin and Isoniazid Tablets

Product Name
异福片
Approval Number
国药准字H20143323
Approval Date
Jun 24, 2020
NMPA

Rifampin Isoniazid and Pyrazinamide Tablets

Product Name
异福酰胺片
Approval Number
国药准字H20143322
Approval Date
Jun 24, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.